OMER FY 2018 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M-53.9% YoY

Gross Profit

$29M98.3% margin

Operating Income

-$112M-375.7% margin

Net Income

-$127M-424.4% margin

EPS (Diluted)

$-2.61

Cash Flow

Operating Cash Flow

-$104M

Free Cash Flow

-$104M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$96M

Total Liabilities

-$4M

Stockholders' Equity

$650M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$65M	-53.9%
Gross Profit	$29M	$64M	-53.9%
Operating Income	-$112M	-$44M	-155.7%
Net Income	-$127M	-$53M	-137.0%